1-18 of 18
Kenneth C. Anderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma

Clinical Trials & Observations
Andrew J. Yee, Jacob P Laubach, Erica L. Campagnaro, Brea C. Lipe, Omar Nadeem, Robb S Friedman, Craig E. Cole, Elizabeth O'Donnell, Giada Bianchi, Andrew R Branagan, Robert L. Schlossman, Samantha J. Shaprio, Cynthia C. Harrington, Jill N. Burke, Marilyn T. Gammon, Kathleen J. Lively, Cassandra A. Reimonn, Danielle X. Andrade, Robert A Redd, Jens G. Lohr, Kenneth C. Anderson, Paul G. Richardson, Noopur Raje
Journal: Blood Advances
Blood Adv bloodadvances.2024014717.
https://doi.org/10.1182/bloodadvances.2024014717
Published: 2024
Includes: Supplemental data
Journal Articles

Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies

Shuhui Deng, Sanika Derebail, Vera Joy Weiler, Jessica Fong Ng, Elena Maroto-Martin, Madhumouli Chatterjee, Giulia Giorgetti, Chandraditya Chakraborty, Poonam Kalhotra, Ting Du, Yao Yao, Rao Prabhala, Masood Shammas, Annamaria Gulla, Anil Aktas Samur, Mehmet Kemal Samur, Lugui Qiu, Kenneth C. Anderson, Mariateresa Fulciniti, Nikhil C. Munshi
Journal: Blood Advances
Blood Adv (2024) 8 (15): 4025–4034.
https://doi.org/10.1182/bloodadvances.2023012298
Published: 2024
Includes: Supplemental data
Journal Articles

Shrinking the divide: improving myeloma CART access

Ajay K. Nooka, Monique A. Hartley-Brown, Kenneth C. Anderson, Sagar Lonial
Journal: Blood Advances
Blood Adv (2024) 8 (1): 248–250.
https://doi.org/10.1182/bloodadvances.2023011659
Published: 2024
Journal Articles

A pandemic preparedness network for individuals living with compromised immune systems

William A. Wood, Kenneth C. Anderson, Shaji K. Kumar, Emily A. Semmel, Kathleen Hewitt, Robert M. Plovnick, Gregory Pappas
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3925–3927.
https://doi.org/10.1182/bloodadvances.2023010035
Published: 2023
Journal Articles

Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15

Rafael Alonso Fernandez, Jessica Encinas Mayoral, Laetitia Pierre-Louis, Yao Yao, Yan Xu, Shidai Mu, Joaquin Martinez-Lopez, Daniel Primo, Takahiro Miyazaki, Rao Prabhala, Kenneth C. Anderson, Willem W. Overwijk, Nikhil C. Munshi, Mariateresa Fulciniti
Journal: Blood Advances
Blood Adv (2023) 7 (1): 9–19.
https://doi.org/10.1182/bloodadvances.2022007985
Published: 2023
Includes: Supplemental data
Journal Articles

Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma

Elizabeth K. O’Donnell, Yael N. Shapiro, Andrew J. Yee, Omar Nadeem, Jacob P. Laubach, Andrew R. Branagan, Kenneth C. Anderson, Clifton C. Mo, Nikhil C. Munshi, Irene M. Ghobrial, Adam S. Sperling, Emerentia A. Agyemang, Jill N. Burke, Cynthia C. Harrington, Bonnie Y. Hu, Paul G. Richardson, Noopur S. Raje, Areej El-Jawahri
Journal: Blood Advances
Blood Adv (2022) 6 (17): 4967–4974.
https://doi.org/10.1182/bloodadvances.2022007127
Published: 2022
Journal Articles

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

Manit Munshi, Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R. Hunter, M. Lia Palomba, Kimon V. Argyropoulos, Christopher J. Patterson, Alexa G. Canning, Kirsten Meid, Joshua Gustine, Andrew R. Branagan, Catherine A. Flynn, Shayna Sarosiek, Jorge J. Castillo, Jinhua Wang, Sara J. Buhrlage, Nathanael S. Gray, Nikhil C. Munshi, Kenneth C. Anderson, Steven P. Treon, Guang Yang
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3332–3338.
https://doi.org/10.1182/bloodadvances.2021006147
Published: 2022
Includes: Supplemental data
Journal Articles

Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH

Yuting Yan, Xiaoqi Qin, Jiahui Liu, Huishou Fan, Wenqiang Yan, Lanting Liu, Chenxing Du, Zhen Yu, Yan Xu, Mu Hao, Shuhui Deng, Weiwei Sui, Rui Lyu, Wei Liu, Qi Wang, Dehui Zou, Linping Hu, Jianxiang Wang, Yu-Tzu Tai, Kenneth C. Anderson, Lei Zhang, Tao Cheng, Anders Zetterberg, Nikhil C. Munshi, Lugui Qiu, Gang An
Journal: Blood Advances
Blood Adv (2022) 6 (2): 441–451.
https://doi.org/10.1182/bloodadvances.2021004992
Published: 2022
Includes: Supplemental data
Journal Articles

Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival

Tianzeng Chen, Matthew Ho, Jenna Briere, Maria Moscvin, Peter G. Czarnecki, Kenneth C. Anderson, T. Keith Blackwell, Giada Bianchi
Journal: Blood Advances
Blood Adv (2022) 6 (2): 429–440.
https://doi.org/10.1182/bloodadvances.2020003820
Published: 2022
Includes: Supplemental data
Journal Articles

ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology

William A. Wood, Peter Marks, Robert M. Plovnick, Kathleen Hewitt, Donna S. Neuberg, Sam Walters, Brendan K. Dolan, Emily A. Tucker, Charles S. Abrams, Alexis A. Thompson, Kenneth C. Anderson, Paul Kluetz, Ann Farrell, Donna Rivera, Matthew Gertzog, Gregory Pappas
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5429–5438.
https://doi.org/10.1182/bloodadvances.2021005902
Published: 2021
Includes: Supplemental data
Journal Articles

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma

Clinical Trials & Observations
Nikhil C. Munshi, Herve Avet-Loiseau, Kenneth C. Anderson, Paola Neri, Bruno Paiva, Mehmet Samur, Meletios Dimopoulos, Margarita Kulakova, Annette Lam, Mahmoud Hashim, Jianming He, Bart Heeg, Jon Ukropec, Jessica Vermeulen, Sarah Cote, Nizar Bahlis
Journal: Blood Advances
Blood Adv (2020) 4 (23): 5988–5999.
https://doi.org/10.1182/bloodadvances.2020002827
Published: 2020
Includes: Supplemental data
Journal Articles

Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub

Clinical Trials & Observations
William A. Wood, Donna S. Neuberg, J. Colton Thompson, Martin S. Tallman, Mikkael A. Sekeres, Laurie H. Sehn, Kenneth C. Anderson, Aaron D. Goldberg, Nathan A. Pennell, Charlotte M. Niemeyer, Emily Tucker, Kathleen Hewitt, Robert M. Plovnick, Lisa K. Hicks
Journal: Blood Advances
Blood Adv (2020) 4 (23): 5966–5975.
https://doi.org/10.1182/bloodadvances.2020003170
Published: 2020
Includes: Supplemental data
Journal Articles

The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models

Shih-Feng Cho, Liang Lin, Lijie Xing, Yuyin Li, Kenneth Wen, Tengteng Yu, Phillip A. Hsieh, Nikhil Munshi, Joachim Wahl, Katja Matthes, Matthias Friedrich, Tara Arvedson, Kenneth C. Anderson, Yu-Tzu Tai
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4195–4207.
https://doi.org/10.1182/bloodadvances.2020002524
Published: 2020
Includes: Supplemental data
Journal Articles

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

Clinical Trials & Observations
Zhaohui Du, Niels Weinhold, Gregory Chi Song, Kristin A. Rand, David J. Van Den Berg, Amie E. Hwang, Xin Sheng, Victor Hom, Sikander Ailawadhi, Ajay K. Nooka, Seema Singhal, Karen Pawlish, Edward S. Peters, Cathryn Bock, Ann Mohrbacher, Alexander Stram, Sonja I. Berndt, William J. Blot, Graham Casey, Victoria L. Stevens, Rick Kittles, Phyllis J. Goodman, W. Ryan Diver, Anselm Hennis, Barbara Nemesure, Eric A. Klein, Benjamin A. Rybicki, Janet L. Stanford, John S. Witte, Lisa Signorello, Esther M. John, Leslie Bernstein, Antoinette M. Stroup, Owen W. Stephens, Maurizio Zangari, Frits Van Rhee, Andrew Olshan, Wei Zheng, Jennifer J. Hu, Regina Ziegler, Sarah J. Nyante, Sue Ann Ingles, Michael F. Press, John David Carpten, Stephen J. Chanock, Jayesh Mehta, Graham A. Colditz, Jeffrey Wolf, Thomas G. Martin, Michael Tomasson, Mark A. Fiala, Howard Terebelo, Nalini Janakiraman, Laurence Kolonel, Kenneth C. Anderson, Loic Le Marchand, Daniel Auclair, Brian C.-H. Chiu, Elad Ziv, Daniel Stram, Ravi Vij, Leon Bernal-Mizrachi, Gareth J. Morgan, Jeffrey A. Zonder, Carol Ann Huff, Sagar Lonial, Robert Z. Orlowski, David V. Conti, Christopher A. Haiman, Wendy Cozen
Journal: Blood Advances
Blood Adv (2020) 4 (1): 181–190.
https://doi.org/10.1182/bloodadvances.2019000491
Published: 2020
Includes: Supplemental data
Journal Articles

Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma

Andrea Schmidts, Maria Ormhøj, Bryan D. Choi, Allison O. Taylor, Amanda A. Bouffard, Irene Scarfò, Rebecca C. Larson, Matthew J. Frigault, Kathleen Gallagher, Ana P. Castano, Lauren S. Riley, Maria L. Cabral, Angela C. Boroughs, Rubí M.-H. Velasco Cárdenas, Wolfgang Schamel, Jing Zhou, Sean Mackay, Yu-Tzu Tai, Kenneth C. Anderson, Marcela V. Maus
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3248–3260.
https://doi.org/10.1182/bloodadvances.2019000703
Published: 2019
Includes: Supplemental data
Journal Articles

The impact of response kinetics for multiple myeloma in the era of novel agents

Clinical Trials & Observations
Yuting Yan, Xuehan Mao, Jiahui Liu, Huishou Fan, Chenxing Du, Zengjun Li, Shuhua Yi, Yan Xu, Rui Lv, Wei Liu, Shuhui Deng, Weiwei Sui, Qi Wang, Dehui Zou, Jianxiang Wang, Tao Cheng, Fenghuang Zhan, Yu-Tzu Tai, Chenglu Yuan, Xin Du, Lugui Qiu, Kenneth C. Anderson, Gang An
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2895–2904.
https://doi.org/10.1182/bloodadvances.2019000432
Published: 2019
Includes: Supplemental data
Journal Articles

Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia

Clinical Trials & Observations
Zachary R. Hunter, Lian Xu, Nickolas Tsakmaklis, Maria G. Demos, Amanda Kofides, Cristina Jimenez, Gloria G. Chan, Jiaji Chen, Xia Liu, Manit Munshi, Joshua Gustine, Kirsten Meid, Christopher J. Patterson, Guang Yang, Toni Dubeau, Mehmet K. Samur, Jorge J. Castillo, Kenneth C. Anderson, Nikhil C. Munshi, Steven P. Treon
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2937–2946.
https://doi.org/10.1182/bloodadvances.2018022962
Published: 2018
Includes: Supplemental data
Journal Articles

Should minimal residual disease negativity be the end point of myeloma therapy?

Clinical Trials & Observations
Kenneth C. Anderson
Journal: Blood Advances
Blood Adv (2017) 1 (8): 517–521.
https://doi.org/10.1182/bloodadvances.2016000117
Published: 2017